An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
Clinical trial NCT07482813 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07482813
- Sponsor
- Paradigm Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2027-07-19
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.